Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Buy
12,391
+108
+0.9% +$12.6K 0.34% 62
2026
Q1
$1.39M Buy
+12,283
New +$1.42M 0.31% 74

Other funds holding MRK

Guidance Capital's MRK Position: Q2 2026 in Review

Guidance Capital increased its Merck (MRK) stake by 0.88% in Q2 2026, buying an estimated $12.6K and bringing the position to 12,391 shares worth $1.58M. The position accounts for 0.34% of the portfolio, ranked #62.

Guidance Capital first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 924 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Guidance Capital held 12,391 shares of Merck worth $1.58M as of Q2 2026.
  • Guidance Capital bought 108 Merck shares in Q2 2026, an estimated $12.6K.
  • Merck made up 0.34% of Guidance Capital's portfolio in Q2 2026, its #62 holding.
  • Guidance Capital first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
  • 924 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Guidance Capital's 13F filing for Q2 2026, filed 20 Jul 2026.